Discover 715 paid clinical trials in Olathe, Kansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 715
Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial
for
Cardiovascular Disease
Location: Overland Park KS, Humble TX, Vaughan, Jacksonville FL,
Sponsor: Amgen
Sex: All
Age: 35 - 70+
Code: NCT07293260
Phase 3, Recruiting
Clinical and Healthcare Outcomes From Real-World Use in the United States of a Companion AI During AF Ablation
for
Atrial Fibrillation
Location: Overland Park KS, Evanston IL, Columbus OH, New York NY
Sponsor: Volta Medical
Sex: All
Age: 21+
Code: NCT06056271
Recruiting
Long-Term Outcomes of LAA Contrast Flow in CT Scans After Endocardial LAA Closure: The CF-CT Registry
for
Atrial Fibrillation, Ischemic Stroke, Acute
Location: Overland Park KS
Sponsor: Kansas City Heart Rhythm Research Foundation
Sex: All
Age: 18+
Code: NCT06075628
Recruiting
Feasibility and Safety of IV Sotalol Administered as a Loading Dose to Initiate Oral Sotalol Therapy
for
Arrhythmias, Cardiac, Atrial Fibrillation
Location: Overland Park KS
Sponsor: Kansas City Heart Rhythm Research Foundation
Sex: All
Age: 18 - 70+
Code: NCT04473807
Recruiting
HS Students Mandatory Universal Student Instruction in CPR Appraised Learning- Is the Mandate Working?
for
Sudden Cardiac Arrest
Location: Overland Park KS
Sponsor: Kansas City Heart Rhythm Research Foundation
Sex: All
Age: 12 - 25
Code: NCT04493970
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
for
Atrial Fibrillation (AF)
Location: Kansas City MO, Kansa City MO, Wichita KS,
Sponsor: Anthos Therapeutics, Inc.
Sex: All
Age: 65+
Code: NCT05712200
Phase 3, Recruiting
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
for
Non-alcoholic Fatty Liver Disease
Location: Kansas City MO, Topeka KS, Springfield MO, St Louis MO,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70+
Code: NCT07221227
Phase 3, Recruiting
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
for
Amblyopia
Location: Prairie Village KS, Kansas City MO, Omaha NE,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 4 - 7
Code: NCT06380517
Phase 3, Recruiting
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
for
Amblyopia
Location: Prairie Village KS, Kansas City MO, Omaha NE,